Reuters logo
2 个月前
BRIEF-TG Therapeutics gives follow-up data from chemo-free triple combination
2017年6月5日 / 下午1点17分 / 2 个月前

BRIEF-TG Therapeutics gives follow-up data from chemo-free triple combination

June 5 (Reuters) - TG Therapeutics Inc

* TG Therapeutics Inc Announces follow-up data from the chemo-free triple combination of TG-1101, TGR-1202, and Ibrutinib at the 53rd annual meeting of the American Society Of Clinical Oncology

* TG Therapeutics Inc - ‍ triple combination appeared to be well tolerated in all patients, with neutropenia and pneumonia​‍​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below